M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway

被引:12
作者
Guo, Fan [1 ,2 ]
Kong, Weina [1 ]
Li, Dewei [3 ]
Zhao, Gang [4 ]
Anwar, Miyessar [1 ]
Xia, Feifei [1 ]
Zhang, Yuanming [5 ]
Ma, Cailing [6 ]
Ma, Xiumin [1 ]
机构
[1] Xinjiang Med Univ, Tumor Hosp, Dept Med Lab Ctr, State Key Lab Pathogenesis Prevent & Treatment Hig, 789 Suzhou Rd, Urumqi 830011, Xinjiang, Peoples R China
[2] Xinjiang Med Univ, Tumor Hosp, Postdoctoral Res Workstn, Urumqi, Xinjiang, Peoples R China
[3] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Resp & Crit Care Med, Urumqi, Xinjiang, Peoples R China
[4] Xinjiang Med Univ, Affiliated Tradit Chinese Med Hosp, Dept Blood Transfus, Urumqi, Xinjiang, Peoples R China
[5] Xinjiang Med Univ, Tumor Hosp, Urumqi, Xinjiang, Peoples R China
[6] Xinjiang Med Univ, Affiliated Hosp 1, Dept Gynecol, State Key Lab Pathogenesis Prevent & Treatment Hig, 137 Li Yu Shan South Rd, Urumqi 830054, Xinjiang, Peoples R China
关键词
Cervical cancer; Tumor-associated macrophages (TAMs); Prognosis; Tumor microenvironment (TME); SQUAMOUS-CELL CARCINOMA; LIGAND; EXPRESSION; INFILTRATION; RESISTANCE; PROGNOSIS; MICROENVIRONMENT; POLARIZATION; PROGRESSION; MECHANISMS; BLOCKADE;
D O I
10.1186/s40001-024-01897-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background and purposePD-1/PD-L1 inhibitors have become a promising therapy. However, the response rate is lower than 30% in patients with cervical cancer (CC), which is related to immunosuppressive components in tumor microenvironment (TME). Tumor-associated macrophages (TAMs), as one of the most important immune cells, are involved in the formation of tumor suppressive microenvironment. Therefore, it will provide a theoretical basis for curative effect improvement about the regulatory mechanism of TAMs on PD-L1 expression.MethodsThe clinical data and pathological tissues of CC patients were collected, and the expressions of PD-L1, CD68 and CD163 were detected by immunohistochemistry. Bioinformatics was used to analyze the macrophage subtypes involved in PD-L1 regulation. A co-culture model was established to observe the effects of TAMs on the morphology, migration and invasion function of CC cells, and the regulatory mechanism of TAMs on PD-L1.ResultsPD-L1 expression on tumor cells could predict the poor prognosis of patients. And there was a strong correlation between PD-L1 expression with CD163+TAMs infiltration. Similarly, PD-L1 expression was associated with M1/M2-type TAMs infiltration in bioinformatics analysis. The results of cell co-culture showed that M1/M2-type TAMs could upregulate PD-L1 expression, especially M2-type TAMs may elevate the PD-L1 expression via PI3K/AKT pathway. Meanwhile, M1/M2-type TAMs can affect the morphological changes, and enhance migration and invasion abilities of CC cells.ConclusionsPD-L1 expression in tumor cells can be used as a prognostic factor and is closely related to CD163+TAMs infiltration. In addition, M2-type TAMs can upregulate PD-L1 expression in CC cells through PI3K/AKT pathway, enhance the migration and invasion capabilities, and affect the tumor progression.
引用
收藏
页数:19
相关论文
共 73 条
[1]   Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies [J].
Anderson, Kristin G. ;
Stromnes, Ingunn M. ;
Greenberg, Philip D. .
CANCER CELL, 2017, 31 (03) :311-325
[2]   In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy [J].
Arlauckas, Sean P. ;
Garris, Christopher S. ;
Kohler, Rainer H. ;
Kitaoka, Maya ;
Cuccarese, Michael F. ;
Yang, Katherine S. ;
Miller, Miles A. ;
Carlson, Jonathan C. ;
Freeman, Gordon J. ;
Anthony, Robert M. ;
Weissleder, Ralph ;
Pittet, Mikael J. .
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (389)
[3]   The Potential Value of the PI3K/Akt/mTOR Signaling Pathway for Assessing Prognosis in Cervical Cancer and as a Target for Therapy [J].
Bahrami, Afsane ;
Hasanzadeh, Malihe ;
Hassanian, Seyed Mahdi ;
ShahidSales, Soodabeh ;
Ghayour-Mobarhan, Majid ;
Ferns, Gordon A. ;
Avan, Amir .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (12) :4163-4169
[4]   Cervical cancer therapies: Current challenges and future perspectives [J].
Burmeister, Carly A. ;
Khan, Saif F. ;
Schafer, Georgia ;
Mbatani, Nomonde ;
Adams, Tracey ;
Moodley, Jennifer ;
Prince, Sharon .
TUMOUR VIRUS RESEARCH, 2022, 13
[5]   The role of PD-1/PD-L1 axis and macrophage in the progression and treatment of cancer [J].
Cai, Jiajing ;
Qi, Qi ;
Qian, Xuemeng ;
Han, Jia ;
Zhu, Xinfang ;
Zhang, Qi ;
Xia, Rong .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (06) :1377-1385
[6]   Elements of cancer immunity and the cancer-immune set point [J].
Chen, Daniel S. ;
Mellman, Ira .
NATURE, 2017, 541 (7637) :321-330
[7]   Targeting tumor-associated macrophages as an antitumor strategy [J].
Cheng, Nan ;
Bai, Xuexia ;
Shu, Yuxin ;
Ahmad, Owais ;
Shen, Pingping .
BIOCHEMICAL PHARMACOLOGY, 2021, 183
[8]   Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma [J].
Chiu, Kuo-Chou ;
Lee, Chien-Hsing ;
Liu, Shyun-Yeu ;
Chou, Yu-Ting ;
Huang, Ren-Yeong ;
Huang, Shih-Ming ;
Shieh, Yi-Shing .
ORAL ONCOLOGY, 2015, 51 (07) :683-689
[9]   Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study [J].
Chung, Hyun Cheol ;
Ros, Willeke ;
Delord, Jean-Pierre ;
Perets, Ruth ;
Italiano, Antoine ;
Shapira-Frommer, Ronnie ;
Manzuk, Lyudmila ;
Piha-Paul, Sarina A. ;
Xu, Lei ;
Zeigenfuss, Susan ;
Pruitt, Scott K. ;
Leary, Alexandra .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (17) :1470-+
[10]   Tissue-Resident and Recruited Macrophages in Primary Tumor and Metastatic Microenvironments: Potential Targets in Cancer Therapy [J].
Cotechini, Tiziana ;
Atallah, Aline ;
Grossman, Arielle .
CELLS, 2021, 10 (04)